Campylobacter spp Bloodstream Infections in Immunocompetent vs Immunodeficient Patients: A Multinational Cohort Study (2009–2024)
Open Access
- 23 June 2026
- journal article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (7)
Abstract
Background: Campylobacter spp bloodstream infections (BSIs) are an emerging clinical challenge, yet information on their clinical features remains limited. We aimed to evaluate their differential clinical characteristics and outcomes in immunocompetent (IC) and immunodeficient (ID) patients. Methods: A multicenter, multinational, retrospective cohort study of consecutive Campylobacter spp BSIs between 2009 and 2024 was carried out. Demographics, Charlson comorbidity index, types of immunodeficiencies, clinical characteristics, and antimicrobial susceptibility were analyzed. The primary outcomes were relapse or reinfection and death (all-cause mortality outcome). Results: A total of 261 episodes were included, 89 (34.1%) in IC and 172 (65.9%) in ID patients. Among the 172 ID patients, 104 (60.5%) and 68 (39.5%) had humoral or nonhumoral immunodeficiency (primary or secondary), and 42 (24.4%) had primary immunodeficiencies (PIDs). Patients with humoral immunodeficiency (humoral-ID patients) were younger (median age, 40 years [interquartile range, 23–66 years]), had lower Charlson comorbidity indexes (2 [1–5]), and had a higher frequency of previous Campylobacter spp infection. Resistance rates to fluoroquinolones (75%) and macrolides (14.5%) were high. BSI relapse or reinfection occurred in 21 (8.0%) patients, mostly humoral-ID patients (n = 19 [18.3%]), 11 (57.9%) of whom had PID. Death occurred with 30 days (all-cause mortality outcome) in 26 patients (9.9%) across the entire cohort; the 30-day mortality rate was lower in humoral-ID (n = 5 [4.8%]) than in IC (n = 12 [13.5%]; P = .05) patients. Conclusions: Humoral-ID patients and those with Campylobacter spp BSI were younger and had fewer comorbid conditions, and Campylobacter coli was the most frequent species. Relapse or reinfection was common in humoral-ID patients, particularly those with PID. The antimicrobial resistance in C coli and Campylobacter jejuni represents a clinical concern.Keywords
Funding Information
- Instituto de Salud Carlos III
- Subdirección General de Evaluación y Fomento de la Investigación
- Ministerio de Ciencia e Innovación (PI23/00279)
- Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas
- Ministerio de Ciencia e Innovación and Unión Europea–NextGenerationEU (CB21/13/00006)
- Ministerio de Ciencia e Innovación and Unión Europea–NextGenerationEU (CB21/13/0049)
- Ministerio de Ciencia e Innovación and Unión Europea–NextGenerationEU (CB21/13/0099)
This publication has 24 references indexed in Scilit:
- Clinical characteristics of campylobacteriosis in cases with immunocompromised and inflammatory bowel disease, compared to immunocompetent patients, a single-center retrospective cohort study in JapanOpen Forum Infectious Diseases, 2025
- Clinical features and outcomes of bacteremic and non-bacteremic Campylobacteriosis: a case–control studyInfection, 2022
- Retrospective Multicentric Study on Campylobacter spp. Bacteremia in France: The Campylobacteremia StudyClinical Infectious Diseases, 2021
- Campylobacter bacteremia in London: A 44-year single-center studyDiagnostic Microbiology and Infectious Disease, 2017
- Campylobacter jejuni and Related Species2014
- Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998–2008Journal of Infection, 2012
- A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998-2007, With Special Reference to Clinical Characteristics and Antimicrobial SusceptibilityClinical Infectious Diseases, 2011
- CampylobacterBacteremia: Clinical Features and Factors Associated with Fatal OutcomeClinical Infectious Diseases, 2008
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Bacteremia Due to Campylobacter Species: Clinical Findings and Antimicrobial Susceptibility PatternsClinical Infectious Diseases, 1997